MorphoSys

MorphoSys tanks after Celgene walks away from $818M pact
Fierce Biotech
Fri, 03/27/15 - 10:13 am
MorphoSys
Celgene
Multiple Myeloma
MorphoSys and Xencor Publish Final Results from Phase 1/2a Trial of MOR208 (XmAb5574) in CLL/SLL at ASH Annual Meeting
Yahoo/PR Newswire
Sun, 12/7/14 - 10:08 am
MorphoSys
Xencor
MOR208
chronic lymphocytic leukemia
leukemia
US FDA grants fast tract status to MorphoSys's MOR208 programme to treat DLBCL
PharmaBiz
Sat, 11/8/14 - 11:39 am
diffuse large B-cell lymphoma
lymphoma
MorphoSys
MOR208
Novartis aims to show strength with muscle wasting drug
Yahoo/Reuters
Fri, 12/6/13 - 10:24 am
muscle wasting
Novartis
sporadic inclusion body myositis
BYM338
MorphoSys
MorphoSys Plans to Raise Spending on Immunotherapy Treatments
Bloomberg
Thu, 08/1/13 - 08:42 am
MorphoSys
immunotherapy
Watch Out for These 3 Biotech Companies
Motley Fool
Thu, 07/4/13 - 11:23 am
Biogen Idec
Biocad
Amgen
M&A
Celgene
MorphoSys
Tecfidera
MorphoSys Rises on $818 Million Drug Alliance
Bloomberg
Thu, 06/27/13 - 10:41 am
MorphoSys
MOR202
Celgene
Multiple Myeloma
Is This GlaxoSmithKline's Next Big Blockbuster?
Motley Fool
Fri, 06/7/13 - 05:47 pm
rheumatoid arthritis
GSK
Humira
AbbVie
MOR103
MorphoSys
Biotech Portfolio Update: 2012 Summary And 2013 Outlook
Seeking Alpha
Mon, 12/24/12 - 10:44 am
Arqule
Array Biopharma
Celldex
Aveo Pharmaceutical
Curis
Exelixis
MorphoSys
Genmab
Novartis
Incyte
Seattle Genetics
YM BioSciences
Blockbuster buzz: 15 top therapies in late-stage development
Fierce Biotech
Thu, 10/11/12 - 10:49 am
vortioxetine
Vectura
tofacitinib
Takeda
T-DM1
Sanofi
Roche
REGN727
Regeneron
Reata
QVA149
Pfizer
Odanacatib
Novartis
MorphoSys
Merck
macitentan
Lundbeck
Immunogen
GSK
GS-7977
Gilead
gantenerumab
Eliquis
darapladib
Bristol-Myers Squibb
Biogen Idec
BG-12
Bayer
Bardoxolone
Anacetrapib
Alpharadin
Algeta
Actelion
AbbVie
MorphoSys Chief Says MOR103 Drug Data Makes Deal More Likely
Bloomberg
Fri, 09/21/12 - 11:35 am
MorphoSys
MOR103
rheumatoid arthritis
Morphosys, Merck & Co. Sign Pact for HuCAL in Vaccine Research
Bloomberg
Mon, 08/1/11 - 10:17 am
vaccines
MorphoSys
Merck
HuCAL
Making sense of the Alzheimer's drug pipeline
Fierce Biotech Research
Tue, 03/15/11 - 12:31 pm
Alzheimer's disease
Razadyne
Nivalin
Ortho-McNeil-Janssen
Exelon
Novartis
Aricept
Eisai
Pfizer
Namenda
Merz
Forest Labs
Eli Lilly
Elan
JNJ
Roche
MorphoSys
Morphosys' Growth Story Remains Intact
Seeking Alpha
Mon, 03/7/11 - 11:42 am
MorphoSys
Immunogen
Micromet
Novartis
MorphoSys Reports Clinical Milestones in Pfizer, OncoMed Pacts
Bloomberg
Mon, 01/31/11 - 07:53 am
MorphoSys
Pfizer
OncoMed
MorphoSys, Daiichi Sankyo Enter Alliance to Develop Antibodies
Bloomberg
Tue, 10/20/09 - 09:07 am
antibody discovery
MorphoSys
Daiichi Sankyo
BioElectronics Announces Completion of Clinical Study -- Preparing FDA 510(K) Pre-Marketing Notifica
PR-USA.net
Sun, 08/30/09 - 10:25 am
MorphoSys

Pages